News
Walgreens to pay $300M to settle with Department of Justice over opioid allegations
Walgreens Boots Alliance has agreed to pay $300 million to settle allegations that it filled millions of invalid prescriptions for opioids and other controlled substances and illegally billed federal programs such as Medicare for those medications, the U.S. Department of Justice announced Monday.
Recently, Walgreens Boots Alliance struck a deal with private ... retailers who closed up shop after being bought by private-equity firms”. At the very least, “the fundamental problems ...
Walgreens Boots Alliance (NASDAQ: WBA) is in a pending acquisition with Sycamore Partners, a private equity firm, to take the ...
NEW YORK — Walgreens Boots Alliance says it has agreed to be acquired by the private equity firm Sycamore Partners as the struggling retailer looks to turn itself around after years of ...
A private equity firm is buying Walgreens, a move that could take the company private this year. Walgreens stock is trading higher on the news, but it's still below the purchase price of ...
Walgreens delivered a better-than-expected fiscal second quarter and a smaller loss a month after announcing that it would be bought by a private equity ... Walgreens Boots Alliance Inc.
“A few weeks ago, Walgreens decided to sell out to a private equity firm, a storied name ... in retail drugstore operator, Walgreens Boots Alliance, Inc. (NASDAQ:WBA) following the wash ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback